Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology
Not yet recruiting · NCT07544953 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology | Alzheimer disease, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy | Not yet recruiting | Not applicable | 2026-04-22 | NCT07544953 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yonsei University | 213 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yonsei University College of Medicine | Seoul | South Korea | 5 |